GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,686 | -41.9% | 6,100 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $13,237 | -99.9% | 6,100 | -99.5% | 0.00% | -99.9% |
| Q3 2022 | $13,830,000 | +23.8% | 1,154,407 | -13.5% | 2.76% | +35.2% |
| Q2 2022 | $11,173,000 | +28.5% | 1,334,887 | +33.2% | 2.04% | +78.3% |
| Q1 2022 | $8,695,000 | -43.8% | 1,001,815 | -26.7% | 1.14% | -50.4% |
| Q4 2021 | $15,461,000 | -20.0% | 1,366,933 | -11.1% | 2.30% | +69.2% |
| Q3 2021 | $19,325,000 | +127.0% | 1,537,333 | +46.6% | 1.36% | +97.8% |
| Q2 2021 | $8,513,000 | -31.7% | 1,048,383 | -22.2% | 0.69% | +64.2% |
| Q1 2021 | $12,472,000 | -9.8% | 1,348,383 | -5.7% | 0.42% | -31.3% |
| Q4 2020 | $13,826,000 | +67.8% | 1,429,683 | +115.4% | 0.61% | +2.3% |
| Q3 2020 | $8,238,000 | -10.0% | 663,794 | -5.7% | 0.60% | -18.1% |
| Q2 2020 | $9,152,000 | -24.1% | 703,999 | -8.7% | 0.73% | -62.7% |
| Q4 2019 | $12,052,000 | – | 771,100 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |